查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1787968

全球兽医治疗市场预测（至 2032 年）：按产品、动物类型、给药途径、通路和地区划分

Veterinary therapeutics Market Forecasts to 2032 - Global Analysis By Product (Veterinary Drugs, Veterinary Vaccines and Medicated Feed Additives), Animal Type, Route of Administration, Distribution Channel and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球兽医治疗市场预计在 2025 年达到 588 亿美元，到 2032 年将达到 1,102 亿美元，预测期内的复合年增长率为 9.4%。

兽医学是兽医学的一个分支学科，专注于运用药理学、免疫学和支持性护理对动物疾病进行诊断、治疗和管理。兽医学涵盖多种介入措施，包括针对不同动物种类的抗生素、疫苗、抗寄生虫药物、止痛药和生物製药。这些治疗策略旨在恢復动物健康、缓解疼痛、预防疾病进展并改善动物整体福祉。兽医学在畜牧生产力、通用感染疾病控制和公共卫生方面也发挥着重要作用。

根据世界动物卫生组织统计，口蹄疫影响全球77.0%的牲畜。

宠物饲养的兴起以及人与动物之间的联繫

宠物拥有量的激增以及人与动物之间日益加深的联繫，大大推动了兽医护理市场的发展。随着宠物日益被视为家庭成员，人们对先进的个人化照护的需求也日益增长，包括慢性疾病的预防和治疗。这种情感连结推动了人们在健康、创新治疗方法和诊断方面的支出增加。此外，人们对宠物健康的日益关注也推动了兽医医疗服务的产品开发和扩展，从而增强了市场在製药、生技药品和伴侣动物护理领域的强劲成长和创新轨迹。

高级兽医护理高成本

先进兽医治疗的高昂成本是市场成长的一大障碍，尤其是在宠物保险有限且负担能力堪忧的新兴市场。如此高昂的费用往往会阻碍宠物饲主和畜牧养殖户及时寻求治疗，导致宠物拥有率下降。经济负担也阻碍了小型诊所提供创新治疗方法，最终阻碍了市场扩张和获得尖端兽医解决方案的管道。

兽医学技术进步

兽医技术的进步正在透过提高诊断准确性、疗效和个人化治疗来改变兽医护理市场。人工智慧诊断、远端医疗和再生疗法等创新正在加速早期疾病的检测并改善治疗效果。智慧型设备与资料分析的融合正在促进即时监控和决策。这些发展不仅提高了临床效率并降低了成本，还扩大了医疗保健的可近性，推动了市场成长并促进了兽医护理的持续创新。

严格的监管核准

严格的监管核准对兽药市场构成了重大障碍。冗长的核准流程、复杂的文件以及严格的安全性和有效性测试，不仅延误了产品的上市，还增加了开发成本。规模较小的公司往往难以满足这些要求，从而限制了创新和市场准入。虽然这些严格的法规对动物福利至关重要，但它们却构成了瓶颈，限制了快速发展和跨地区新型治疗方法的可近性。

COVID-19的影响

新冠疫情对兽医治疗市场产生了许多影响。最初，封锁和旅行限制扰乱了兽医服务和供应链，导致非紧急治疗延误。然而，这场危机也提高了人们对通用感染疾病的认识，并凸显了建立健全动物卫生系统的重要性。在疫情封锁期间，宠物拥有量激增，推动了伴侣动物药物的需求。随着全球适应疫情，远端医疗和居家照护解决方案日益受到青睐，重塑了动物照护的交付模式。

兽用疫苗市场预计将成为预测期内最大的市场

兽用疫苗领域预计将在预测期内占据最大的市场占有率，因为其预防特性可以降低治疗成本并支持永续的动物健康管理。疫苗开发技术的进步，例如重组疫苗和基于载体的平台，正在推动各种治疗方法的创新。此外，疫苗还有助于遏制通用感染疾病的传播并确保更安全的食品供应，从而促进公共卫生。这一成长领域不仅补充了治疗性介入，而且还透过改善疾病控制来加速市场扩张。

预计网路商店部分在预测期内将实现最高的复合年增长率。

预计网路商店细分市场将在预测期内实现最高增长率，因为这些平台简化了宠物饲主和牲畜饲养者的产品发现流程，透过具有竞争力的价格提高了可负担性，并增强了偏远地区的市场渗透率。此外，电子商务促进了直接面向消费者的配送，提高了便利性并促进了兽医护理方案的依从性。与人工智慧驱动的建议和订阅模式的整合将进一步优化治疗效果，推动市场持续成长。

占比最大的地区：

由于宠物拥有量不断增长以及人们对动物健康的意识不断增强，预计亚太地区将在预测期内占据最大的市场占有率。印度、中国和韩国等国家正在投资先进的治疗和预防性医疗保健，推动对疫苗、诊断和药物的需求。技术创新和政府措施正在加强兽医基础设施建设，改善疾病控制，并支持粮食安全。这个充满活力的市场正在推动全部区域的经济发展，并提高动物福利标准。

复合年增长率最高的地区：

由于伴侣动物医疗保健支出高昂且兽医基础设施先进，北美预计将在预测期内实现最高的复合年增长率。该地区受益于强大的兽医诊所网络、广泛的保险覆盖以及生物製药和精准诊断等创新疗法的早期采用。政府的支持性法规和日益增强的通用感染疾病预防意识将进一步提振市场。北美技术先进的生态系统和对动物福利的重视将继续推动对有效治疗方案的需求。

免费客製化服务：

此报告的订阅者可以使用以下免费自订选项之一：

  • 公司简介
    • 全面分析其他市场参与者（最多 3 家公司）
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球兽医治疗市场（按产品）

  • 兽药
    • 抗感染药物
    • 抗发炎药物
    • 杀虫剂
  • 兽用疫苗
    • 惰性
    • 减毒活疫苗
    • 重组
  • 药用饲料添加剂
    • 抗生素
    • 球虫药物
    • 驱虫药

6. 全球兽医治疗市场（依动物类型）

  • 伴侣动物
    • 狗
    • 马
    • 猫
  • 家畜
    • 牛
    • 绵羊/山羊
    • 家禽
    • 猪

7. 全球兽医治疗市场（依给药途径）

  • 口服
  • 肠外
  • 局部的
  • 气雾剂

8. 全球兽医治疗市场（依通路）

  • 兽医医院和诊所
  • 饲料店
  • 药局
  • 网路商店
  • 其他的

9. 全球兽医治疗市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章：主要发展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章：公司简介

  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Merck Animal Health
  • Boehringer Ingelheim Animal Health
  • Ceva Sante Animale
  • Virbac
  • Vetoquinol SA
  • Dechra Pharmaceuticals PLC
  • IDEXX Laboratories, Inc.
  • Phibro Animal Health Corporation
  • Norbrook Laboratories Ltd.
  • Zydus Animal Health
  • Kindred Biosciences, Inc.
  • Neogen Corporation
  • Bimeda Animal Health
  • Biogenesis Bago
  • Ourofino Saude Animal
  • Kyoritsu Seiyaku Corporation
Product Code: SMRC30233

According to Stratistics MRC, the Global Veterinary Therapeutics Market is accounted for $58.8 billion in 2025 and is expected to reach $110.2 billion by 2032 growing at a CAGR of 9.4% during the forecast period. Veterinary therapeutics refers to the branch of veterinary medicine that focuses on diagnosing, treating, and managing animal diseases using pharmacological, immunological, and supportive therapies. It encompasses a wide range of interventions, including antibiotics, vaccines, antiparasitics, analgesics, and biologics tailored to various species. These therapeutic strategies aim to restore health, alleviate pain, prevent disease progression, and improve overall animal welfare. Veterinary therapeutics also plays a vital role in livestock productivity, zoonotic disease control, and public health.

According to the World Organization for Animal Health, foot and mouth disease affects 77.0% of the global livestock population.

Market Dynamics:

Driver:

Rising Pet Ownership & Human-Animal Bond

The surge in pet ownership and deepening human-animal bonds is significantly propelling the Veterinary therapeutics market. With pets increasingly seen as family, there's rising demand for advanced, personalized care, including preventive and chronic condition treatments. This emotional connection drives higher spending on wellness, innovative therapies, and diagnostics. Moreover, growing awareness of pet health fosters product development and veterinary service expansion, reinforcing the market's trajectory toward robust growth and innovation across pharmaceuticals, biologics, and companion animal care segments.

Restraint:

High Cost of Advanced Veterinary therapeutics

The high cost of advanced Veterinary therapeutics poses a significant barrier to market growth, especially in developing regions where pet insurance is limited and affordability is a concern. These costly treatments often deter pet owners and livestock farmers from seeking timely care, leading to reduced adoption rates. The financial burden also discourages smaller clinics from stocking innovative therapies, ultimately hindering market expansion and access to cutting-edge veterinary solutions.

Opportunity:

Technological Advancements in Veterinary Medicine

Technological advancements in veterinary medicine are transforming the Veterinary therapeutics market by enhancing diagnostic precision, treatment efficacy, and personalized care. Innovations such as AI-driven diagnostics, telemedicine, and regenerative therapies are accelerating early disease detection and improving outcomes. The integration of smart devices and data analytics boosts real-time monitoring and decision-making. These developments not only increase clinical efficiency and reduce costs but also expand access to care, driving market growth and fostering continuous innovation in Veterinary therapeutics.

Threat:

Stringent Regulatory Approvals

Stringent regulatory approvals pose a significant hindrance to the Veterinary therapeutics market. Lengthy approval timelines, complex documentation, and rigorous safety and efficacy trials delay product launches and increase development costs. Smaller players often struggle to meet these demands, limiting innovation and market entry. These strict regulations, though essential for animal welfare, act as a bottleneck, restricting swift advancements and the availability of novel therapies across regions.

Covid-19 Impact

The COVID-19 pandemic had a mixed impact on the Veterinary therapeutics market. Initially, lockdowns and movement restrictions disrupted veterinary services, supply chains, and delayed non-urgent treatments. However, the crisis also heightened awareness of zoonotic diseases, emphasizing the need for robust animal health systems. Pet adoption surged during lockdowns, increasing demand for companion animal therapeutics. As the world adapted, telemedicine and home-care solutions gained traction, reshaping veterinary care delivery models.

The veterinary vaccines segment is expected to be the largest during the forecast period

The veterinary vaccines segment is expected to account for the largest market share during the forecast period because their preventive nature lowers treatment costs and supports sustainable animal health management. Technological advancements in vaccine development-such as recombinant and vector-based platforms-drive innovation across therapeutics. Additionally, vaccines contribute to public health by curbing zoonotic transmissions and ensuring safer food supplies. This growing segment not only complements therapeutic interventions but also accelerates market expansion through improved disease control.

The online stores segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the online stores segment is predicted to witness the highest growth rate as these platforms streamline product discovery for pet owners and livestock managers, improve affordability through competitive pricing, and enhance market penetration in remote areas. Additionally, e-commerce facilitates direct-to-consumer delivery, fostering convenience and compliance with veterinary care regimens. Their integration with AI-powered recommendations and subscription models is further optimizing therapeutic outcomes and driving sustained market growth.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising pet ownership and heightened awareness of animal health. Countries like India, China, and South Korea are investing in advanced treatments and preventive care, boosting demand for vaccines, diagnostics, and pharmaceuticals. Technological innovations and government initiatives are enhancing veterinary infrastructure, improving disease management, and supporting food security. This dynamic market is fostering economic development and elevating standards in animal welfare across the region.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to high spending on companion animal healthcare, and advanced veterinary infrastructure. The region benefits from a strong network of veterinary clinics, widespread insurance coverage, and early adoption of innovative treatments like biologics and precision diagnostics. Supportive government regulations and growing awareness about zoonotic disease control further boost the market. North America's technologically advanced ecosystem and emphasis on animal welfare continue to drive the demand for effective therapeutic solutions.

Key players in the market

Some of the key players profiled in the Veterinary therapeutics Market include Zoetis Inc., Elanco Animal Health Incorporated, Merck Animal Health, Boehringer Ingelheim Animal Health, Ceva Sante Animale, Virbac, Vetoquinol S.A., Dechra Pharmaceuticals PLC, IDEXX Laboratories, Inc., Phibro Animal Health Corporation, Norbrook Laboratories Ltd., Zydus Animal Health, Kindred Biosciences, Inc., Neogen Corporation, Bimeda Animal Health, Biogenesis Bago, Ourofino Saude Animal and Kyoritsu Seiyaku Corporation.

Key Developments:

In June 2025, Infosys has entered into a strategic, long-term consulting partnership with Zoetis, the world's leading animal health company, Under this deal, Infosys will support Zoetis by integrating advanced AI driven solutions, automation, and digital enhancements into their IT operations. The goal is to boost agility and streamline systems, enabling Zoetis to better serve veterinarians, livestock producers, and pet owners globally.

In April 2025, Elanco has entered into a strategic research partnership with WEDterinary LLC, to pursue groundbreaking therapies for chronic kidney disease (CKD) in cats and explore approaches for extending healthy lifespan in pets. The first phase of this collaboration involves pioneering targeted gene therapy specifically aimed at treating feline CKD, while also delving into emerging technologies in life-extension for companion animals.

Products Covered:

  • Veterinary Drugs
  • Veterinary Vaccines
  • Medicated Feed Additives

Animal Types Covered:

  • Companion Animals
  • Livestock Animals

Routes of Administration Covered:

  • Oral
  • Parenteral
  • Topical
  • Aerosol

Distribution Channels Covered:

  • Veterinary Hospitals & Clinics
  • Feed Stores
  • Pharmacies
  • Online Stores
  • Other Distribution Channels

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Veterinary therapeutics Market, By Product

  • 5.1 Introduction
  • 5.2 Veterinary Drugs
    • 5.2.1 Anti-infectives
    • 5.2.2 Anti-inflammatory
    • 5.2.3 Parasiticides
  • 5.3 Veterinary Vaccines
    • 5.3.1 Inactivated
    • 5.3.2 Live Attenuated
    • 5.3.3 Recombinant
  • 5.4 Medicated Feed Additives
    • 5.4.1 Antimicrobials
    • 5.4.2 Anticoccidials
    • 5.4.3 Antiparasitics

6 Global Veterinary therapeutics Market, By Animal Type

  • 6.1 Introduction
  • 6.2 Companion Animals
    • 6.2.1 Dogs
    • 6.2.2 Horses
    • 6.2.3 Cats
  • 6.3 Livestock Animals
    • 6.3.1 Cattle
    • 6.3.2 Sheep & Goats
    • 6.3.3 Poultry
    • 6.3.4 Swine

7 Global Veterinary therapeutics Market, By Route of Administration

  • 7.1 Introduction
  • 7.2 Oral
  • 7.3 Parenteral
  • 7.4 Topical
  • 7.5 Aerosol

8 Global Veterinary therapeutics Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Veterinary Hospitals & Clinics
  • 8.3 Feed Stores
  • 8.4 Pharmacies
  • 8.5 Online Stores
  • 8.6 Other Distribution Channels

9 Global Veterinary therapeutics Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Zoetis Inc.
  • 11.2 Elanco Animal Health Incorporated
  • 11.3 Merck Animal Health
  • 11.4 Boehringer Ingelheim Animal Health
  • 11.5 Ceva Sante Animale
  • 11.6 Virbac
  • 11.7 Vetoquinol S.A.
  • 11.8 Dechra Pharmaceuticals PLC
  • 11.9 IDEXX Laboratories, Inc.
  • 11.10 Phibro Animal Health Corporation
  • 11.11 Norbrook Laboratories Ltd.
  • 11.12 Zydus Animal Health
  • 11.13 Kindred Biosciences, Inc.
  • 11.14 Neogen Corporation
  • 11.15 Bimeda Animal Health
  • 11.16 Biogenesis Bago
  • 11.17 Ourofino Saude Animal
  • 11.18 Kyoritsu Seiyaku Corporation

List of Tables

  • 1 Global Veterinary therapeutics Market Outlook, By Region (2024-2032) ($MN)
  • 2 Global Veterinary therapeutics Market Outlook, By Product (2024-2032) ($MN)
  • 3 Global Veterinary therapeutics Market Outlook, By Veterinary Drugs (2024-2032) ($MN)
  • 4 Global Veterinary therapeutics Market Outlook, By Anti-infectives (2024-2032) ($MN)
  • 5 Global Veterinary therapeutics Market Outlook, By Anti-inflammatory (2024-2032) ($MN)
  • 6 Global Veterinary therapeutics Market Outlook, By Parasiticides (2024-2032) ($MN)
  • 7 Global Veterinary therapeutics Market Outlook, By Veterinary Vaccines (2024-2032) ($MN)
  • 8 Global Veterinary therapeutics Market Outlook, By Inactivated (2024-2032) ($MN)
  • 9 Global Veterinary therapeutics Market Outlook, By Live Attenuated (2024-2032) ($MN)
  • 10 Global Veterinary therapeutics Market Outlook, By Recombinant (2024-2032) ($MN)
  • 11 Global Veterinary therapeutics Market Outlook, By Medicated Feed Additives (2024-2032) ($MN)
  • 12 Global Veterinary therapeutics Market Outlook, By Antimicrobials (2024-2032) ($MN)
  • 13 Global Veterinary therapeutics Market Outlook, By Anticoccidials (2024-2032) ($MN)
  • 14 Global Veterinary therapeutics Market Outlook, By Antiparasitics (2024-2032) ($MN)
  • 15 Global Veterinary therapeutics Market Outlook, By Animal Type (2024-2032) ($MN)
  • 16 Global Veterinary therapeutics Market Outlook, By Companion Animals (2024-2032) ($MN)
  • 17 Global Veterinary therapeutics Market Outlook, By Dogs (2024-2032) ($MN)
  • 18 Global Veterinary therapeutics Market Outlook, By Horses (2024-2032) ($MN)
  • 19 Global Veterinary therapeutics Market Outlook, By Cats (2024-2032) ($MN)
  • 20 Global Veterinary therapeutics Market Outlook, By Livestock Animals (2024-2032) ($MN)
  • 21 Global Veterinary therapeutics Market Outlook, By Cattle (2024-2032) ($MN)
  • 22 Global Veterinary therapeutics Market Outlook, By Sheep & Goats (2024-2032) ($MN)
  • 23 Global Veterinary therapeutics Market Outlook, By Poultry (2024-2032) ($MN)
  • 24 Global Veterinary therapeutics Market Outlook, By Swine (2024-2032) ($MN)
  • 25 Global Veterinary therapeutics Market Outlook, By Route of Administration (2024-2032) ($MN)
  • 26 Global Veterinary therapeutics Market Outlook, By Oral (2024-2032) ($MN)
  • 27 Global Veterinary therapeutics Market Outlook, By Parenteral (2024-2032) ($MN)
  • 28 Global Veterinary therapeutics Market Outlook, By Topical (2024-2032) ($MN)
  • 29 Global Veterinary therapeutics Market Outlook, By Aerosol (2024-2032) ($MN)
  • 30 Global Veterinary therapeutics Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • 31 Global Veterinary therapeutics Market Outlook, By Veterinary Hospitals & Clinics (2024-2032) ($MN)
  • 32 Global Veterinary therapeutics Market Outlook, By Feed Stores (2024-2032) ($MN)
  • 33 Global Veterinary therapeutics Market Outlook, By Pharmacies (2024-2032) ($MN)
  • 34 Global Veterinary therapeutics Market Outlook, By Online Stores (2024-2032) ($MN)
  • 35 Global Veterinary therapeutics Market Outlook, By Other Distribution Channels (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.